FLT3 and acute myeloid leukemia: We found that AML cell lines treated with both ABT-199 and HHT showed a much better inhibitory effect especially in OCL-AML2, OCL-AML3, MOLM-13, and MV4-11cell lines with FLT3-ITD mutation than those treated with each reagent alone in a time-dependent manner.